stonks4u
Sign up free
RYTM logo

RYTM Rhythm Pharmaceuticals, Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$115.48
-0.54 (-0.47%)

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies i…

Market Cap: $7.92Bwww.rhythmtx.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 12Aug 12

Quote

Day Range
$113.66 – $117.13
52-Week Range
$74.50 – $122.20
Volume
$329.7K
Market Cap
$7.92B
50-Day Avg
$104.70
200-Day Avg
$99.17
Prev Close
$116.02
Open
$114.23

Valuation & Ratios

P/E Ratio
-34.42
EPS
$-3.02
P/B Ratio
25.76
P/S Ratio
36.66
Debt/Equity
0.01
Current Ratio
4.41
Dividend Yield
+0.0%
Gross Margin
+89.7%

Returns & Efficiency

Return on Equity
-72.8%
Return on Assets
-40.9%
FCF Yield
-1.7%
EV/EBITDA
-39.66

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$189.76M$-196.54M$-3.11
2024$130.13M$-260.60M$-4.34
2023$77.43M$-184.68M$-3.20
2022$23.64M$-181.12M$-3.51
2021$3.15M$-69.61M$-1.37

Social Signal Score

50
5d
50
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1

Earnings

Tue, Nov 3(in 3 months)

Consensus estimate $-0.73 per share

3of 7 quarters beat consensus

Typical surprise -4.3% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, Aug 4$-0.73 vs $-0.81beat
  • Tue, May 5$-0.83 vs $-0.86beat
  • Thu, Feb 26$-0.73 vs $-0.79beat
  • Tue, Nov 4$-0.82 vs $-0.72miss
  • Tue, Aug 5$-0.75 vs $-0.66miss
  • Wed, May 7$-0.81 vs $-0.69miss

Estimates and results for RYTM via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

RYTMhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsbenzinga.com·3d ago·Neutral

    Why Is Rhythm Pharmaceuticals Stock Trading Higher On Wednesday? Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) shares are trading higher on Wednesday.

    View source ↗